THURSDAY, DECEMBER 13, 2018

Transcription

1 THURSDAY, DECEMBER 13, :00 am Welcome and Introduction 7:10 am The Hans E. Shapira Lecture Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Peter Scardino, MD EPIDEMIOLOGY AND EARLY DIAGNOSIS OF PROSTATE CANCER (PART 1) Panelists: Giuseppe Carrieri, MD; Philippa Cheetham, MD; Ralph Clayman, MD 7:40 am Management of Diet, Exercise on Prostate John Kellogg Parsons, MD 8:00 am 3D Live Surgery: Robot Assisted Radical Prostatectomy Surgeon: Moderators: Ketan K. Badani, MD; Alberto Martini, MD Panelists: Fabrizio Dal Moro, MD; Francesco Montorsi, MD; Alexandre Mottrie, MD, PhD; Peter Scardino, MD 9:30 am Q&A for Live Surgery 9:45 am Radiotherapy Michael Zelefsky, MD 10:00 am Emperor of All Maladies: Cancer and the Implications for Prostate Cancer Siddhartha Mukherjee, MD Featured Guest Speaker 11:00 am Coffee Break EPIDEMIOLOGY AND EARLY DIAGNOSIS OF PROSTATE CANCER (PART 2) Panelists: TBD 11:10 am Biomarkers in Prostate Cancer Christopher Evans, MD 11:20 am Imaging in Prostate Cancer Art Rastinehad, DO 11:35 am Introduction to Sit-Down MRI Trial Page 1/15

2 11:45 am Targeted-Biopsy Techniques Samir Taneja, MD 12:00 pm When to Skip Biopsy: Before Diagnosis, During AS, Follow-Up of FT Arnauld Villers, MD, PhD 12:10 pm How Has the Task Force Hurt Cancer Screening? Jim Hu, MD, MPH 12:20 pm Q&A (Epidemiology and Early Diagnosis of Prostate Cancer (Part 2) 12:30 pm LUNCH SYMPOSIUM MAIN AFTERNOON SESSION STAGING, IMAGING, AND GENOMICS Panelists: Christopher Barbieri, MD, PhD; Francesco Montorsi, MD; Alexandre Mottrie, MD, PhD; Kenneth Rosenzweig, MD 1:30 pm In Search of a Man Eater 1:50 pm Genomic Landscape of Prostate Cancer Arul Chinnaiyan, MD, PhD 2:20 pm Current Status of Nomograms and Imaging Markers in Prostate Cancer Christopher Barbieri, MD, PhD 2:30 pm Genomics in Prostate Cancer Christopher Evans, MD 2:45 pm Q&A (Staging, Imaging and Genomics) 2:55 pm DEBATE Imaging is More Appropriate for Identifying Unfavorable Pathology in Early Prostate Cancer - Art Rastinehad, DO Genomics is Best for Identifying Unfavorable Pathology in Early Prostate Cancer (TBD) MANAGEMENT OF VERY LOW RISK AND LOW RISK PROSTATE CANCER Panelists: John Denstedt; Lee Richstone, MD; Atsushi Takenaka, MD, PhD 3:25 pm New Anatomy of Prostate for Robotic Prostatectomy Page 2/15

3 4:10 pm Anatomical Prostatectomy Thomas Bessede, MD 4:25 pm Management of BPH in Active Surveillance Patients Steven Kaplan, MD 4:35pm Q&A (Management of Very Low Risk and Low Risk Prostate Cancer) BEST TREATMENT FOR AGGRESSIVE PROSTATE CANCER Panelists: Bobby Liaw, MD; Daniel W. Lin, MD; William Oh, MD; Peter Scardino, MD 4:45 pm State of ART Lecture Innovative Drug Development and the Academic Urologic Oncologist: A Personal Experience Arie Belldegrun, MD FOCAL THERAPY Panelists: Jonathan Coleman, MD; Jim Hu, MD; Aaron Katz, MD; Art Rastinehad, DO 5:15pm Focal Therapy: Is It Ready for Prime Time? Herbert Lepor, MD 5:30 pm Focal Therapy for Prostate Cancer Art Rastinehad, DO 5:40 pm Partial Gland Ablation and Focal Therapy for Prostate Cancer Jonathan Coleman, MD 5:50 pm The Role of Salvage Cryotherapy and the Outcomes Aaron Katz, MD 6:00 pm Complications of Focal Therapy Rene Javier Sotelo, MD SURGICAL TREATMENT OF INTERMEDIATE RISK PROSTATE CANCER Panelists: Markus Hohenfellner, MD; Prasanna Sooriakumaran, MD, PhD 6:10pm QOL Comparison Between Open vs Robotic Prostatectomy Misop Han, MD 6:20 pm Metastatic Hormone Sensitive Prostate Cancer: What the Urologist Needs to Know Michael Cookson, MD 6:30 pm RARP: Surgical Steps for Better Oncological and Functional Outcomes Jorn Witt, MD Page 3/15

4 6:40 pm Global Perspectives in Robotic Surgery: A Healthy Market is a Competitive One Maurizio Buscarini, MD 6:50 pm Q&A (Surgical Treatment of Intermediate Risk Prostate Cancer) 7:00 pm Conclusion Page 4/15

5 THURSDAY, DECEMBER 13, 2018 BREAKOUT SESSION: IMMUNOTHERAPY & TUMOR MICROENVIRONMENT (PART I) Moderators: Arie Belldegrun, MD; Nina Bhardwaj, MD, PhD 1:30 pm Cancer Immunotherapy and Targeting Innate Immune Cells Nina Bhardwaj, MD, PhD 1:40 pm Q&A (Cancer Immunotherapy and Targeting Innate Immune Cells) 1:43 pm Prostate Cancer Radiomics Study Stefanie Hectors, PhD 1:53 pm Q&A (Prostate Cancer Radiomics) 1:56 pm Targeting DNA Repair Deficiency in Prostate Cancer Joseph W. Kim, MD 2:06 pm Q&A (Targeting DNA Repair Deficiency in Prostate Cancer) 2:09 pm PRINT Study Discussion Bobby Liaw, MD 2:19 pm Q&A PRINT Study Discussion 2:22 pm Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced Prostate Cancer: Opportunities for Personalized Care Aria Olumi, MD 2:32 pm Q&A (Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced Prostate Cancer: Opportunities for Personalized Care) 2:35 pm Combination Immunotherapy Strategies Ravi Madan, MD 2:45 pm Q&A (Combination Immunotherapy Strategies) 2:48 pm A Pragmatic Approach to Radiation Strictures Jerry Blaivas, MD 2:58 pm Q&A (A Pragmatic Approach to Radiation Strictures) Page 5/15

6 3:01 pm Urethral Strictures Rajveer S. Purohit, MD 3:11 pm Q&A (Management of Incontinence after Radiation or Surgery) 3:14 pm Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of Post-Prostatectomy Incontinence Neil H. Grafstein, MD 3:24 pm Q&A (Same Old Sling? The Evolution of Perineal Sling Surgery for Treatment of Post-Prostatectomy Incontinence) 3:27 pm Treatment of Male Hypogonadism Using Non-Testosterone Therapies Natan Bar-Chama, MD 3:37 pm Q&A (Treatment of Male Hypogonadism Using Non-Testosterone Therapies) 3:40 pm Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site Daniel Gainsburg, MD 3:50 pm Q&A (Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site) 3:53 pm Quality of Life after Urologic Cancer Nihal Mohamed, PhD 4:03 pm Q&A (Quality of Life after Urologic Cancer) 4:06 pm Advances in Artificial Intelligence Applied to Prostate Cancer Gerardo J. Fernandez, MD 4:16pm Q&A (Advances in Artificial Intelligence Applied to Prostate Cancer) 4:19 pm Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy Using CyberKnife Jonathan Haas, MD 4:29 pm Q&A (Treatment of Locally Recurrent Prostate Cancer After Whole Gland Cryotherapy Using CyberKnife) 4:31 pm JOIN THE MAIN SESSION Page 6/15